research Suprabulbar Thinning of Hair in Telogen Effluvium
Hair is thinner near the scalp in acute hair shedding conditions.
Search
for
Sort by
Research
30 / 1000+ results 
research Severe Hair Loss During Inpatient Rehabilitation Due to Telogen Effluvium: A Case Report
A woman had temporary hair loss due to stress from a spinal cord injury.
research Characteristics of Hair Loss in COVID-19 Patients in Thailand
COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.
research Interest of a Cinchona Succirubra Extract and Its Association with Caffeine in Hair Loss
Cinchona succirubra extract with caffeine reduces hair loss and strengthens hair.
research Telogen Effluvium, Diagnosis and Management: A Narrative Review
Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.
research Alopecia Areata Incognita
Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.
research Telogen Effluvium: A Common Form of Hair Loss
Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.
research Capillary Impacts of Covid-19: The Link Between Acute Telogen Effluvium and Alopecia Areata - An Integrative Review
Covid-19 can cause hair loss due to immune and psychological factors.
research Chronic Telogen Effluvium: Increased Scalp Hair Shedding in Middle-Aged Women
Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.
research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium
Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.
research COVID-19-Induced Hair Shedding and Related Risk Factors: A Saudi Perspective
Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.
research Acute Diffuse And Total Alopecia: A New Subtype Of Alopecia Areata With A Favorable Prognosis
A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.
research Acute Diffuse and Total Alopecia of the Female Scalp
A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.
research RASopathic Alopecia: Hair Changes Associated with Vemurafenib Therapy
Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.
research Hair Manifestations of Systemic Disease
Hair changes can indicate systemic diseases or medication effects.
research Recurrent Episodes of Hair Loss in a 37-Year-Old Woman
The woman's hair loss was mainly due to stress and low iron levels, and her hair grew back after treatment.
research Chronic Telogen Effluvium
Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.
research Rehabilitating the Journal Club: A Review of Journal Clubs in Physical Medicine and Rehabilitation
The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.
research Alopecia Areata and Alopecia Areata Incognita
Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.
research Telogen Effluvium: A Comprehensive Review
Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.
research Noninflammatory, Nonpruritic Alopecia of Horses
Some horses lose hair without inflammation or itching due to various conditions, and while mainly a cosmetic issue, diagnosis requires examination and biopsies, and breeding is not advised if it's hereditary.
research Prevalence of Hair Loss After COVID-19 Vaccination Among an Egyptian Population: A Cross-Sectional Study
About a quarter of the participants experienced hair loss after COVID-19 vaccination.
research Expert Consensus on the Management of Telogen Effluvium in India
Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.
research Forehead Reduction and Orbital Contouring in Facial Feminization Surgery for Transgender Females
Forehead reduction and orbital contouring are important for satisfactory facial feminization in transgender females, with high satisfaction and low long-term problems.
research Diseases of Hair and Nails
The document says that there are treatments for hair and nail diseases.
research Distinguishing Diffuse Alopecia Areata from Pattern Hair Loss Using CD3+ T Cells
CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.
research An Overview of Management of Drug-Induced Hair and Nail Disorders
Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.
research Disorders of Hair Growth and the Pilosebaceous Unit: Facts and Controversies
Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.
research Clinical Hair Loss: Diagnosis and Treatment
The review suggests limited treatments for common hair loss conditions, with potential for future improvements.
research Postmenopausal Alopecia (Hair Loss)
Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.